Group One Trading’s Flexion Therapeutics, Inc. FLXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-23,900
| Closed | -$146K | – | 9197 |
|
|
2021
Q3 | $146K | Buy |
23,900
+2,700
| +13% | +$16.8K | ﹤0.01% | 5504 |
|
|
2021
Q2 | $174K | Sell |
21,200
-22,800
| -52% | -$194K | ﹤0.01% | 5382 |
|
|
2021
Q1 | $394K | Buy |
44,000
+34,500
| +363% | +$395K | ﹤0.01% | 4312 |
|
|
2020
Q4 | $110K | Sell |
9,500
-100
| -1% | -$1.16K | ﹤0.01% | 4501 |
|
|
2020
Q3 | $100K | Sell |
9,600
-23,400
| -71% | -$287K | ﹤0.01% | 4200 |
|
|
2020
Q2 | $434K | Sell |
33,000
-22,800
| -41% | -$236K | ﹤0.01% | 2751 |
|
|
2020
Q1 | $439K | Sell |
55,800
-49,300
| -47% | -$743K | ﹤0.01% | 2146 |
|
|
2019
Q4 | $2.18M | Buy |
105,100
+68,800
| +190% | +$1.16M | 0.01% | 1227 |
|
|
2019
Q3 | $497K | Buy |
36,300
+32,100
| +764% | +$381K | ﹤0.01% | 2340 |
|
|
2019
Q2 | $52K | Buy |
4,200
+3,400
| +425% | +$39.2K | ﹤0.01% | 3756 |
|
|
2019
Q1 | $10K | Sell |
800
-22,300
| -97% | -$298K | ﹤0.01% | 4286 |
|
|
2018
Q4 | $261K | Buy |
23,100
+19,100
| +478% | +$299K | ﹤0.01% | 2479 |
|
|
2018
Q3 | $75K | Sell |
4,000
-10,400
| -72% | -$239K | ﹤0.01% | 3730 |
|
|
2018
Q2 | $372K | Buy |
14,400
+1,500
| +12% | +$38.9K | ﹤0.01% | 2550 |
|
|
2018
Q1 | $289K | Sell |
12,900
-25,400
| -66% | -$620K | ﹤0.01% | 2501 |
|
|
2017
Q4 | $959K | Buy |
38,300
+28,500
| +291% | +$698K | 0.01% | 1732 |
|
|
2017
Q3 | $237K | Sell |
9,800
-7,900
| -45% | -$186K | ﹤0.01% | 2646 |
|
|
2017
Q2 | $358K | Buy |
17,700
+7,700
| +77% | +$160K | ﹤0.01% | 2207 |
|
|
2017
Q1 | $269K | Buy |
10,000
+9,100
| +1,011% | +$186K | ﹤0.01% | 2310 |
|
|
2016
Q4 | $17K | Buy |
+900
| New | +$17.2K | ﹤0.01% | 3772 |
|
|
2016
Q3 | – | Sell |
-1,000
| Closed | -$15K | – | 5057 |
|
|
2016
Q2 | $15K | Buy |
+1,000
| New | +$12.6K | ﹤0.01% | 3924 |
|
|
2016
Q1 | – | Sell |
-12,800
| Closed | -$247K | – | 5131 |
|
|
2015
Q4 | $247K | Buy |
12,800
+3,600
| +39% | +$62.5K | ﹤0.01% | 2333 |
|
|
2015
Q3 | $137K | Buy |
+9,200
| New | +$216K | ﹤0.01% | 2804 |
|
Group One Trading's FLXN Position: Q4 2021 in Review
Group One Trading sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2021, closing a stake of 10,833 shares — an estimated $66K sold.
Group One Trading first reported a position in FLXN in Q3 2015 and held it in 14 quarters. The position peaked at $227K in Q1 2018. 1 fund tracked by Wall St. Rank holds FLXN as of Q4 2021.
- Group One Trading reported no remaining Flexion Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
- Group One Trading sold 10,833 Flexion Therapeutics, Inc. shares in Q4 2021, an estimated $66K.
- Group One Trading first reported a position in Flexion Therapeutics, Inc. in Q3 2015 and held it in 14 quarters.
- Group One Trading's Flexion Therapeutics, Inc. position peaked at $227K in Q1 2018.
- 1 fund tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2021.
Based on Group One Trading's 13F filing for Q4 2021, filed 11 Feb 2022.